Clexane and Uterine enlargement - a phase IV clinical study of FDA data

Summary:

Uterine enlargement is reported as a side effect among people who take Clexane (enoxaparin sodium), especially for people who are 40-49 old, also take Diclofenac, and have Agranulocytosis.

The phase IV clinical study analyzes which people have Uterine enlargement when taking Clexane. It is created by eHealthMe based on reports of 14,633 people who have side effects when taking Clexane from the FDA, and is updated regularly.

What is Clexane?

Clexane has active ingredients of enoxaparin sodium. eHealthMe is studying from 14,679 Clexane users. Check the latest studies of Clexane.

What is Uterine enlargement?

Uterine enlargement is found to be associated with 244 drugs and 261 conditions by eHealthMe. Check the latest studies of Uterine enlargement.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

14,633 people reported to have side effects when taking Clexane.
Among them, 15 people (0.1%) have Uterine enlargement.

Could Clexane cause Uterine enlargement?

Among these 15 people:

What is the age of people who have Uterine enlargement when taking Clexane? *

What are other drugs people take besides Clexane? *

Morphine: 14 people, 93.33%
Lyrica: 14 people, 93.33%
Diclofenac: 14 people, 93.33%
Neulasta: 13 people, 86.67%
Movicol: 13 people, 86.67%
Acetylsalicylic Acid: 13 people, 86.67%
Paracetamol: 12 people, 80.00%
Valsartan And Hydrochlorothiazide: 2 people, 13.33%
Doxil: 2 people, 13.33%

What are other side effects people have besides Uterine enlargement? *

Weight Loss: 14 people, 93.33%
Neurological Decompensation (inability of brain to maintain proper function): 14 people, 93.33%
Monoplegia (a paralysis of a single limb): 14 people, 93.33%
Lung Disorder (lung disease): 14 people, 93.33%
Klebsiella Infection: 14 people, 93.33%
Joint Pain: 14 people, 93.33%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 14 people, 93.33%
Hypoaesthesia (reduced sense of touch or sensation): 14 people, 93.33%
Hyperhidrosis (abnormally increased sweating): 14 people, 93.33%
Hernia (hernia happens when part of an internal organ or tissue bulges through a weak area of muscle): 14 people, 93.33%

What are the existing conditions these people have? *

Pneumonia: 14 people, 93.33%
Pain: 14 people, 93.33%
Hodgkin's Lymphoma (cancer originating from white blood cells): 14 people, 93.33%
High Blood Pressure: 14 people, 93.33%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 14 people, 93.33%
Pain In Extremity: 13 people, 86.67%
Back Pain: 11 people, 73.33%

* Approximation only. Some reports may have incomplete information.

Do you take Clexane and have Uterine enlargement?

- Check whether Uterine enlargement is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Clexane:

Clexane (14,679 reports)

Browse all side effects of Clexane:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Uterine enlargement:

Uterine enlargement (244 drugs)

Browse all the conditions that are associated with Uterine enlargement:

Uterine enlargement (261 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on enoxaparin sodium (the active ingredients of Clexane) and Clexane (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.